13 September 2016 - CADTH is inviting patient group comments and feedback on the proposed revisions to the patient input template to be used in both the Common Drug Review and pan-Canadian Oncology Drug Review programs.

CADTH is inviting stakeholder comments on proposed changes to the patient input template for the CADTH Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review (pCODR). Patient input is used by CADTH review teams and by the expert committees of the CDR and pCODR programs: the CADTH Canadian Drug Expert Committee (CDEC) or the pCODR Expert Review Committee (pERC).

Read CADTH article